Back
Enliven Therapeutics Vs. Vincerx Pharma Industry Stock Comparison
Buy
58
ELVN
Enliven Therapeutics
Last Price:
27.82
Seasonality Move:
-12%
Sell
14
VINC
Vincerx Pharma
Last Price:
0.34
Seasonality Move:
3.02%
Buy
58
Enliven Therapeutics (ELVN)
is a Buy
Is Enliven Therapeutics a Buy, Sell or Hold?
- The current Enliven Therapeutics [ELVN] share price is $28.38. The Score for ELVN is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- ELVN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
14
Vincerx Pharma (VINC)
is a Sell
Is Vincerx Pharma a Buy, Sell or Hold?
- The current Vincerx Pharma [VINC] share price is $0.35. The Score for VINC is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- VINC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ELVN Stock Price Chart
What is Enliven Therapeutics's stock price today?
-
The Enliven Therapeutics share price today is $28.38
The current trend is moderately bullish and ELVN is experiencing slight selling pressure.
VINC Stock Price Chart
What is Vincerx Pharma's stock price today?
-
The Vincerx Pharma share price today is $0.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VINC is experiencing slight selling pressure.
ELVN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.04 | Buy |
Relative Strength Index (14 RSI): | 62.6 | Buy |
Chaikin Money Flow: | -29113 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.01 - 28.99) | Buy |
Bollinger Bands (100): | (21.59 - 26.47) | Buy |
VINC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 27.98 | Sell |
Chaikin Money Flow: | -32452 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.35 - 0.65) | Sell |
Bollinger Bands (100): | (0.51 - 0.77) | Sell |
ELVN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.77 | Sell |
20-day SMA: | 28.12 | Buy |
50-day SMA: | 25.08 | Buy |
200-day SMA: | 21.13 | Buy |
8-day EMA: | 28.56 | Sell |
20-day EMA: | 27.79 | Buy |
50-day EMA: | 25.97 | Buy |
200-day EMA: | 21.93 | Buy |
VINC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.37 | Sell |
20-day SMA: | 0.45 | Sell |
50-day SMA: | 0.62 | Sell |
200-day SMA: | 1.57 | Sell |
8-day EMA: | 0.38 | Sell |
20-day EMA: | 0.44 | Sell |
50-day EMA: | 0.56 | Sell |
200-day EMA: | 1.07 | Sell |
Enliven Therapeutics Earnings Growth & ELVN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.48 per share.
Vincerx Pharma Earnings Growth & VINC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and a decrease next year of $0.02 per share.
Enliven Therapeutics Technical Analysis
Oct 17 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vincerx Pharma Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |